Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Ozone | 10 | 2018 | 757 | 3.67 | Why? |
| Hydrotherapy | 5 | 2018 | 14 | 3.63 | Why? |
| Oils | 5 | 2018 | 71 | 3.58 | Why? |
| Dermatitis, Atopic | 5 | 2019 | 714 | 1.71 | Why? |
| Staphylococcal Skin Infections | 2 | 2018 | 32 | 1.43 | Why? |
| Herpes Zoster | 2 | 2020 | 331 | 1.06 | Why? |
| Water | 2 | 2018 | 765 | 1.00 | Why? |
| Staphylococcus aureus | 3 | 2018 | 844 | 0.99 | Why? |
| Air Conditioning | 2 | 2020 | 215 | 0.86 | Why? |
| Skin | 4 | 2019 | 2096 | 0.75 | Why? |
| Rubella | 1 | 2020 | 127 | 0.75 | Why? |
| Tinea Pedis | 1 | 2018 | 6 | 0.75 | Why? |
| Allylamine | 1 | 2018 | 3 | 0.75 | Why? |
| Ketoconazole | 1 | 2018 | 14 | 0.75 | Why? |
| Irritants | 1 | 2018 | 28 | 0.74 | Why? |
| Desmogleins | 1 | 2017 | 1 | 0.70 | Why? |
| Keratosis | 1 | 2017 | 16 | 0.68 | Why? |
| Chickenpox | 1 | 2020 | 194 | 0.67 | Why? |
| Skin Tests | 1 | 2018 | 229 | 0.65 | Why? |
| Candida albicans | 1 | 2018 | 217 | 0.63 | Why? |
| Anti-Infective Agents | 2 | 2018 | 1766 | 0.61 | Why? |
| Pruritus | 1 | 2018 | 215 | 0.61 | Why? |
| Pemphigoid, Bullous | 1 | 2017 | 89 | 0.59 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 2 | 2018 | 711 | 0.54 | Why? |
| Immunoglobulin E | 1 | 2017 | 557 | 0.51 | Why? |
| Measles | 1 | 2020 | 608 | 0.49 | Why? |
| Pseudomonas aeruginosa | 1 | 2018 | 652 | 0.49 | Why? |
| Administration, Topical | 3 | 2018 | 272 | 0.49 | Why? |
| Interleukins | 1 | 2018 | 762 | 0.47 | Why? |
| Dermatologic Agents | 1 | 2018 | 489 | 0.46 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.41 | Why? |
| RNA, Long Noncoding | 3 | 2019 | 408 | 0.38 | Why? |
| Baths | 2 | 2018 | 62 | 0.35 | Why? |
| Antioxidants | 1 | 2018 | 1593 | 0.35 | Why? |
| Antifungal Agents | 1 | 2018 | 1828 | 0.33 | Why? |
| Gastrointestinal Microbiome | 1 | 2019 | 1961 | 0.29 | Why? |
| Skin Diseases | 2 | 2018 | 2509 | 0.27 | Why? |
| Psoriasis | 1 | 2018 | 1739 | 0.26 | Why? |
| Coinfection | 5 | 2020 | 6820 | 0.25 | Why? |
| Drug Administration Schedule | 2 | 2018 | 2324 | 0.21 | Why? |
| Microbial Sensitivity Tests | 3 | 2018 | 2886 | 0.21 | Why? |
| Symbiosis | 1 | 2019 | 38 | 0.20 | Why? |
| Melanocytes | 1 | 2019 | 44 | 0.19 | Why? |
| Flumethasone | 1 | 2018 | 1 | 0.19 | Why? |
| Camellia | 1 | 2018 | 3 | 0.19 | Why? |
| Stem Cell Niche | 1 | 2018 | 16 | 0.19 | Why? |
| Anti-Bacterial Agents | 2 | 2018 | 10083 | 0.19 | Why? |
| Mupirocin | 1 | 2018 | 22 | 0.18 | Why? |
| Combined Modality Therapy | 2 | 2018 | 3395 | 0.18 | Why? |
| Ultraviolet Rays | 2 | 2019 | 1272 | 0.18 | Why? |
| Skin Pigmentation | 1 | 2019 | 98 | 0.18 | Why? |
| Ointments | 1 | 2018 | 54 | 0.18 | Why? |
| Restaurants | 1 | 2020 | 246 | 0.18 | Why? |
| Myofibroblasts | 1 | 2018 | 61 | 0.18 | Why? |
| Skin Cream | 1 | 2018 | 66 | 0.18 | Why? |
| Ovalbumin | 1 | 2017 | 84 | 0.18 | Why? |
| Calcitriol | 1 | 2018 | 84 | 0.17 | Why? |
| Non-Fibrillar Collagens | 1 | 2017 | 9 | 0.17 | Why? |
| Disease Outbreaks | 3 | 2020 | 27595 | 0.17 | Why? |
| Plant Oils | 1 | 2018 | 86 | 0.17 | Why? |
| Acyclovir | 1 | 2018 | 154 | 0.17 | Why? |
| Enterotoxins | 1 | 2017 | 115 | 0.17 | Why? |
| Guinea Pigs | 1 | 2018 | 420 | 0.16 | Why? |
| Hand, Foot and Mouth Disease | 1 | 2018 | 115 | 0.16 | Why? |
| Cosmetics | 1 | 2018 | 100 | 0.16 | Why? |
| Microscopy, Confocal | 1 | 2018 | 343 | 0.16 | Why? |
| Valine | 1 | 2018 | 359 | 0.15 | Why? |
| Enterovirus A, Human | 1 | 2018 | 180 | 0.15 | Why? |
| Low-Level Light Therapy | 1 | 2018 | 129 | 0.15 | Why? |
| Therapies, Investigational | 1 | 2018 | 235 | 0.15 | Why? |
| Picornaviridae Infections | 1 | 2020 | 544 | 0.15 | Why? |
| Intestine, Small | 1 | 2018 | 336 | 0.14 | Why? |
| Chi-Square Distribution | 1 | 2018 | 961 | 0.14 | Why? |
| Case-Control Studies | 3 | 2018 | 17671 | 0.14 | Why? |
| Pain Measurement | 1 | 2018 | 533 | 0.14 | Why? |
| China | 9 | 2020 | 50654 | 0.14 | Why? |
| Rhinovirus | 1 | 2020 | 979 | 0.14 | Why? |
| MAP Kinase Signaling System | 1 | 2017 | 360 | 0.14 | Why? |
| Biological Therapy | 1 | 2019 | 456 | 0.14 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.13 | Why? |
| Stress, Physiological | 1 | 2018 | 378 | 0.13 | Why? |
| Autoantigens | 1 | 2017 | 388 | 0.13 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.13 | Why? |
| Cellular Senescence | 1 | 2017 | 326 | 0.13 | Why? |
| Microbial Viability | 1 | 2017 | 406 | 0.13 | Why? |
| Dermoscopy | 1 | 2018 | 346 | 0.13 | Why? |
| Islam | 1 | 2020 | 545 | 0.13 | Why? |
| Dengue Virus | 1 | 2020 | 910 | 0.12 | Why? |
| Travel-Related Illness | 1 | 2020 | 1357 | 0.12 | Why? |
| Membrane Glycoproteins | 2 | 2019 | 2273 | 0.12 | Why? |
| Glucocorticoids | 2 | 2018 | 4431 | 0.11 | Why? |
| Humans | 29 | 2020 | 930598 | 0.11 | Why? |
| Treatment Outcome | 4 | 2018 | 51732 | 0.11 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.11 | Why? |
| Pressure Ulcer | 1 | 2017 | 398 | 0.11 | Why? |
| Betacoronavirus | 9 | 2020 | 204454 | 0.11 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.10 | Why? |
| Rats | 1 | 2018 | 2764 | 0.10 | Why? |
| Pandemics | 12 | 2020 | 389249 | 0.10 | Why? |
| Intestinal Mucosa | 1 | 2018 | 1046 | 0.10 | Why? |
| Biomarkers, Tumor | 1 | 2018 | 1314 | 0.10 | Why? |
| Pain Management | 1 | 2018 | 854 | 0.09 | Why? |
| Immune System | 1 | 2019 | 1479 | 0.09 | Why? |
| Vaccination Coverage | 1 | 2018 | 1249 | 0.09 | Why? |
| Community-Acquired Infections | 1 | 2020 | 2328 | 0.09 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.09 | Why? |
| Dengue | 1 | 2020 | 1565 | 0.08 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 1261 | 0.08 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.08 | Why? |
| Animals | 5 | 2019 | 78931 | 0.08 | Why? |
| Drug Evaluation, Preclinical | 1 | 2018 | 3347 | 0.08 | Why? |
| Methylprednisolone | 1 | 2017 | 2107 | 0.08 | Why? |
| Family | 1 | 2020 | 2909 | 0.08 | Why? |
| Autoantibodies | 1 | 2017 | 2094 | 0.07 | Why? |
| Influenza, Human | 2 | 2020 | 10779 | 0.07 | Why? |
| Antiviral Agents | 1 | 2018 | 41703 | 0.07 | Why? |
| Parents | 1 | 2018 | 2758 | 0.07 | Why? |
| RNA, Small Interfering | 2 | 2019 | 817 | 0.06 | Why? |
| Vitamin D | 1 | 2017 | 2904 | 0.06 | Why? |
| Hobbies | 1 | 2020 | 9 | 0.06 | Why? |
| Cell Proliferation | 2 | 2018 | 1973 | 0.05 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.05 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.05 | Why? |
| Monophenol Monooxygenase | 1 | 2019 | 11 | 0.05 | Why? |
| Child | 3 | 2018 | 70012 | 0.05 | Why? |
| Feedback, Physiological | 1 | 2019 | 56 | 0.05 | Why? |
| Intramolecular Oxidoreductases | 1 | 2019 | 38 | 0.05 | Why? |
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 92 | 0.05 | Why? |
| Adult | 6 | 2020 | 244371 | 0.05 | Why? |
| Anti-Inflammatory Agents | 1 | 2018 | 6153 | 0.05 | Why? |
| Singing | 1 | 2020 | 143 | 0.05 | Why? |
| Cellular Microenvironment | 1 | 2018 | 55 | 0.05 | Why? |
| Oxidoreductases | 1 | 2019 | 136 | 0.05 | Why? |
| Infant | 2 | 2018 | 30274 | 0.04 | Why? |
| Masks | 1 | 2020 | 8528 | 0.04 | Why? |
| Matrix Metalloproteinase 1 | 1 | 2017 | 60 | 0.04 | Why? |
| Viral Vaccines | 1 | 2018 | 7560 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Male | 9 | 2020 | 367725 | 0.04 | Why? |
| Epithelial-Mesenchymal Transition | 1 | 2018 | 242 | 0.04 | Why? |
| In Vitro Techniques | 1 | 2018 | 1027 | 0.03 | Why? |
| Phosphorylation | 1 | 2017 | 1060 | 0.03 | Why? |
| Down-Regulation | 1 | 2019 | 1416 | 0.03 | Why? |
| Fibroblasts | 1 | 2017 | 839 | 0.03 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.03 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1014 | 0.03 | Why? |
| Signal Transduction | 2 | 2019 | 7207 | 0.03 | Why? |
| Cell Differentiation | 1 | 2018 | 1338 | 0.03 | Why? |
| Cell Survival | 1 | 2017 | 1581 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.03 | Why? |
| Up-Regulation | 1 | 2019 | 2249 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2017 | 1136 | 0.03 | Why? |
| Female | 7 | 2020 | 380317 | 0.03 | Why? |
| Vaccines, Inactivated | 1 | 2018 | 1562 | 0.03 | Why? |
| Middle Aged | 5 | 2020 | 270681 | 0.03 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.03 | Why? |
| Needs Assessment | 1 | 2020 | 2352 | 0.03 | Why? |
| Singapore | 1 | 2020 | 3641 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2018 | 48226 | 0.02 | Why? |
| Interviews as Topic | 1 | 2018 | 1952 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2019 | 2483 | 0.02 | Why? |
| Immunization | 1 | 2017 | 2019 | 0.02 | Why? |
| Apoptosis | 1 | 2018 | 2335 | 0.02 | Why? |
| Mice | 2 | 2018 | 21357 | 0.02 | Why? |
| Aged | 3 | 2020 | 215776 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2020 | 3129 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2017 | 5814 | 0.02 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.02 | Why? |
| Schools | 1 | 2020 | 4187 | 0.02 | Why? |
| Leadership | 1 | 2018 | 2241 | 0.02 | Why? |
| Patient Discharge | 1 | 2020 | 5696 | 0.02 | Why? |
| Developing Countries | 1 | 2020 | 4283 | 0.02 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.02 | Why? |
| Cell Line | 1 | 2019 | 12040 | 0.02 | Why? |
| Students | 1 | 2020 | 5255 | 0.01 | Why? |
| Air Pollution | 1 | 2020 | 3504 | 0.01 | Why? |
| Inpatients | 1 | 2017 | 5161 | 0.01 | Why? |
| Interleukin-6 | 1 | 2019 | 7522 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Patient Acceptance of Health Care | 1 | 2018 | 5002 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Retrospective Studies | 1 | 2017 | 105322 | 0.00 | Why? |
Lu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(196)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(64)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_